Journal articles on the topic 'Lobular breast cancer, prognosis, next-generation sequencing'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Lobular breast cancer, prognosis, next-generation sequencing.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
O'Keefe, Kaitlyn, Andrew Elliott, Chad Livasy, Meghan Steiner, Irene Kang, Dave S. B. Hoon, Wolfgang Michael Korn, et al. "HER2 alterations and prognostic implications in all subtypes of breast cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 1041. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.1041.
Full textO'Keefe, Kaitlyn, Andrew Elliott, Chad Livasy, Meghan Steiner, Irene Kang, Dave S. B. Hoon, Wolfgang Michael Korn, et al. "HER2 alterations and prognostic implications in all subtypes of breast cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 1041. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.1041.
Full textWard, Elspeth, Anna Blümel, Emer Conroy, Grainne Cremin, Binbin Gao, William Gallagher, Idalia Cruz, et al. "Abstract PD14-07: Bromodomain and Extra-Terminal motif (BET) inhibitors are a rational therapeutic choice for treatment of invasive lobular carcinoma." Cancer Research 82, no. 4_Supplement (February 15, 2022): PD14–07—PD14–07. http://dx.doi.org/10.1158/1538-7445.sabcs21-pd14-07.
Full textCarbognin, Luisa, Michele Simbolo, Caterina Vicentini, Isabella Sperduti, Anna Caliò, Francesco Schettini, Maria Vittoria Dieci, et al. "Next-generation targeted sequencing (NGTS) investigating CDK4 as a prognostic driver in pure invasive lobular breast carcinoma (ILC): Preliminary results in early-stage patients (pts) stratified according to a validated clinico-pathological model." Journal of Clinical Oncology 36, no. 15_suppl (May 20, 2018): 542. http://dx.doi.org/10.1200/jco.2018.36.15_suppl.542.
Full textLouie, Anna D., Rani Chudasama, Sharon Wu, Marzia Capelletti, Daniel Magee, W. Michael Korn, Virginia Kaklamani, et al. "Abstract PD6-04: Mutational landscape and immune infiltration of breast cancer metastases to gynecologic and other organs." Cancer Research 82, no. 4_Supplement (February 15, 2022): PD6–04—PD6–04. http://dx.doi.org/10.1158/1538-7445.sabcs21-pd6-04.
Full textSturgill, Emma G., Amanda Misch, Rebecca Lachs, Carissa C. Jones, Dan Schlauch, Suzanne F. Jones, Mythili Shastry, et al. "Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics." JCO Precision Oncology, no. 5 (August 2021): 1297–311. http://dx.doi.org/10.1200/po.20.00469.
Full textKrishnan, Preethi, Sunita Ghosh, Bo Wang, Mieke Heyns, Kathryn Graham, John R. Mackey, Olga Kovalchuk, and Sambasivarao Damaraju. "Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis." PLOS ONE 11, no. 9 (September 15, 2016): e0162622. http://dx.doi.org/10.1371/journal.pone.0162622.
Full textHuang, Xin, Huanwen M. Wu, Changbin Zhu, Di Shao, Dan Guo, Yidong Zhou, Yan Lin, et al. "Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 558. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.558.
Full textUji, Kumiko, Yasuto Naoi, Naofumi Kagara, Masafumi Shimoda, Atsushi Shimomura, Naomi Maruyama, Kenzo Shimazu, Seung Jin Kim, and Shinzaburo Noguchi. "Significance of TP53 mutations determined by next-generation “deep” sequencing in prognosis of estrogen receptor-positive breast cancer." Cancer Letters 342, no. 1 (January 2014): 19–26. http://dx.doi.org/10.1016/j.canlet.2013.08.028.
Full textBatista, Marta Vaz, Diogo Alpuim Costa, Paula Borralho, and Sofia Braga. "Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time." Case Reports in Oncology 14, no. 2 (August 16, 2021): 1212–19. http://dx.doi.org/10.1159/000517441.
Full textVan Thuan, Tran, Nguyen Van Chu, Pham Hong Khoa, Nguyen Tien Quang, Dao Van Tu, Nguyen Thi Quynh Tho, Phung Thi Huyen, et al. "A Novel BRCA1 Gene Mutation Detected With Breast Cancer in a Vietnamese Family by Targeted Next-Generation Sequencing: A Case Report." Breast Cancer: Basic and Clinical Research 14 (January 2020): 117822342090155. http://dx.doi.org/10.1177/1178223420901555.
Full textSchmidt, Marcus, and Anne-Sophie Heimes. "Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice." Cancers 13, no. 19 (September 29, 2021): 4883. http://dx.doi.org/10.3390/cancers13194883.
Full textChang, Ya-Sian, Chieh-Min Chang, Chien-Yu Lin, Dy-San Chao, Hsi-Yuan Huang, and Jan-Gowth Chang. "Pathway Mutations in Breast Cancer Using Whole-Exome Sequencing." Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28, no. 2 (March 27, 2020): 107–16. http://dx.doi.org/10.3727/096504019x15698362825407.
Full textChristgen, Matthias, Stephan Bartels, Jana L. van Luttikhuizen, Janin Bublitz, Luisa U. Rieger, Henriette Christgen, Helge Stark, et al. "E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements." Modern Pathology 33, no. 12 (June 22, 2020): 2483–98. http://dx.doi.org/10.1038/s41379-020-0591-3.
Full textHe, Lin, Ellen Araj, and Yan Peng. "HER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic Features." Current Oncology 28, no. 3 (April 24, 2021): 1608–17. http://dx.doi.org/10.3390/curroncol28030150.
Full textIgnatova, A. V., A. M. Mudunov, S. О. Podvyaznikov, and Yu V. Alymov. "Mammary analogue secretory carcinoma of the salivary gland with NTRK fusions: new approaches for diagnostics and targeted therapy (review)." Head and Neck Tumors (HNT) 10, no. 2 (July 24, 2020): 69–78. http://dx.doi.org/10.17650/2222-1468-2020-10-2-69-78.
Full textAdes, Felipe, Dimitrios Zardavas, Ivana Bozovic-Spasojevic, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Giuseppe Viale, Christos Sotiriou, and Martine Piccart. "Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives." Journal of Clinical Oncology 32, no. 25 (September 1, 2014): 2794–803. http://dx.doi.org/10.1200/jco.2013.54.1870.
Full textNagahashi, Masayuki, Tetsu Hayashida, Yuko Kitagawa, Manabu Futamura, Kazuhiro Yoshida, Takashi Kuwayama, Seigo Nakamura, et al. "Comprehensive genomic sequencing for triple negative breast cancer in Japan." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e23122-e23122. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23122.
Full textLiu, Yuhong, Yixiang Gan, NiJiati AiErken, Wei Chen, Shiwei Zhang, Jie Ouyang, Leli Zeng, and Di Tang. "Combining Organoid Models with Next-Generation Sequencing to Reveal Tumor Heterogeneity and Predict Therapeutic Response in Breast Cancer." Journal of Oncology 2022 (August 22, 2022): 1–13. http://dx.doi.org/10.1155/2022/9390912.
Full textJancalek, Radim, Marek Vecera, Frantisek Siegl, Jiri Sana, Karolina Trachtova, Michal Hendrych, Vaclav Vybihal, et al. "PATH-02. ANALYSIS OF MICRORNA EXPRESSION IN BRAIN METASTASES USING NEXT-GENERATION SEQUENCING." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii149—vii150. http://dx.doi.org/10.1093/neuonc/noac209.575.
Full textCarbognin, Luisa, Michele Simbolo, Anna Caliò, Caterina Vicentini, Pietro Delfino, Isabella Sperduti, Matteo Fassan, et al. "Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model." Breast 50 (April 2020): 56–63. http://dx.doi.org/10.1016/j.breast.2020.01.034.
Full textLi, Shunying, Hongna Lai, Jieqiong Liu, Yujie Liu, Liang Jin, Yudong Li, Fengtao Liu, et al. "Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy." JCO Precision Oncology, no. 4 (September 2020): 244–57. http://dx.doi.org/10.1200/po.19.00292.
Full textSekkate, Sakina, Laure Ladrat, Christelle Pouliquen, Celine Callens, Jean Francois Geay, and Philippe Beuzeboc. "Neuroendocrine differentiation in metastatic breast cancer following CDK 4/6 inhibitors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e13029-e13029. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e13029.
Full textGrogan, Nicole Margo, Yi-Mi Wu, Dan R. Robinson, James M. Rae, Norah Lynn Henry, Daniel F. Hayes, Michelle F. Jacobs, et al. "Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 10527. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10527.
Full textPizzuti, Laura, Eriseld Krasniqi, Chiara Mandoj, Daniele Marinelli, Domenico Sergi, Elisabetta Capomolla, Giancarlo Paoletti, et al. "Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial." Cancers 12, no. 4 (April 1, 2020): 849. http://dx.doi.org/10.3390/cancers12040849.
Full textHerrera Juarez, Mercedes, Pablo Tolosa Ortega, Ana Sanchez de Torre, and Eva Ciruelos Gil. "Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features." Breast Care 15, no. 3 (2020): 208–16. http://dx.doi.org/10.1159/000508758.
Full textEllsworth, Darrell L., Clesson E. Turner, and Rachel E. Ellsworth. "A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements." Journal of Oncology 2019 (July 9, 2019): 1–10. http://dx.doi.org/10.1155/2019/4382606.
Full textHlaváč, Viktor, Radka Václavíková, Veronika Brynychová, Renata Koževnikovová, Katerina Kopečková, David Vrána, Jiří Gatěk, and Pavel Souček. "Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response." International Journal of Molecular Sciences 21, no. 24 (December 15, 2020): 9556. http://dx.doi.org/10.3390/ijms21249556.
Full textAfkhami, Michelle, Idoroenyi Usua Amanam, Patricia A. Aoun, Dan Schmolze, Susan Yost, Paul Henry Frankel, Kim Nguyen, Wai (Kim) Wai Yu, Thehang H. Luu, and Yuan Yuan. "Genomic profiling of metaplastic breast cancer: A single center experience." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e12041-e12041. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12041.
Full textHlaváč, Viktor, Radka Václavíková, Veronika Brynychová, Pavel Ostašov, Renata Koževnikovová, Katerina Kopečková, David Vrána, Jiří Gatěk, and Pavel Souček. "Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response." International Journal of Molecular Sciences 22, no. 6 (March 10, 2021): 2826. http://dx.doi.org/10.3390/ijms22062826.
Full textChen, Xinxin, Lehong Zhang, Min Yuan, Ziqiao Kuang, Ying Zou, Tian Tang, Wangjian Zhang, et al. "Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3." Current Cancer Drug Targets 20, no. 1 (January 27, 2020): 76–83. http://dx.doi.org/10.2174/1568009619666190718124541.
Full textCaparica, Rafael, Matteo Lambertini, Noam Pondé, Debora Fumagalli, Evandro de Azambuja, and Martine Piccart. "Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives." Therapeutic Advances in Medical Oncology 11 (January 2019): 175883591982771. http://dx.doi.org/10.1177/1758835919827714.
Full textMeric-Bernstam, Funda, Xiaofeng Zheng, Maryam Shariati, Senthil Damodaran, Chetna Wathoo, Lauren Brusco, Mehmet Esat Demirhan, et al. "Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer." JCO Precision Oncology, no. 2 (November 2018): 1–15. http://dx.doi.org/10.1200/po.17.00245.
Full textKuo, Sung Hsin, Po-Han Lin, Shi-Yi Yang, and Chiun-Sheng Huang. "Association of discovered novel SNPs of FGFR2 and MAP3K1 genes from next-generation sequencing with the prognosis of hormone receptor-positive early breast cancer patients." Journal of Clinical Oncology 34, no. 15_suppl (May 20, 2016): e12054-e12054. http://dx.doi.org/10.1200/jco.2016.34.15_suppl.e12054.
Full textCosentino, Dorian, and Maria Carla Valli. "Clinical Application of Integrated Treatments in Breast Cancer." Tumori Journal 84, no. 2 (March 1998): 223–28. http://dx.doi.org/10.1177/030089169808400221.
Full textBasu, Gargi D., Tracey White, Janine R. LoBello, Ahmet Kurdoglu, Jeffrey M. Trent, Matthew J. Halbert, Thomas Royce, and Joyce O'Shaughnessy. "Assessment of ESR1 and ERBB2 mutations in estrogen receptor positive (ER+) metastatic breast cancers (MBC)." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 1040. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1040.
Full textWang, Peng, Qiaoling Zhang, Lei Han, Yanan Cheng, Zengfeng Sun, Qiang Yin, Zhen Zhang, and Jinpu Yu. "Genomic Instability in Cerebrospinal Fluid Cell-Free DNA Predicts Poor Prognosis in Solid Tumor Patients with Meningeal Metastasis." Cancers 14, no. 20 (October 14, 2022): 5028. http://dx.doi.org/10.3390/cancers14205028.
Full textSemiglazov, V. F., M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, and P. V. Krivorotko. "Post-neoadjuvant treatment of breast cancer." Meditsinskiy sovet = Medical Council, no. 9 (July 30, 2020): 232–41. http://dx.doi.org/10.21518/2079-701x-2020-9-232-241.
Full textBar, Isabelle, Ahmad Merhi, Fadi Abdel-Sater, Abduelhakem Ben Addi, Sara Sollennita, Jean-Luc Canon, and Paul Delrée. "The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer." Journal of Histochemistry & Cytochemistry 65, no. 6 (April 12, 2017): 335–46. http://dx.doi.org/10.1369/0022155417702849.
Full textCriscitiello, Carmen, Antonio Marra, and Giuseppe Curigliano. "PIK3CA Mutation Assessment in HR+/HER2− Metastatic Breast Cancer: Overview for Oncology Clinical Practice." Journal of Molecular Pathology 2, no. 1 (March 11, 2021): 42–54. http://dx.doi.org/10.3390/jmp2010005.
Full textJung, Seung Pil, Soo Youn Bae, Jeong Hyeon Lee, and Joung Won Bae. "Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer." Journal of Global Oncology 5, suppl (October 7, 2019): 119. http://dx.doi.org/10.1200/jgo.2019.5.suppl.119.
Full textWongchenko, Matthew J., Sung-Bae Kim, Cristina Saura, Mafalda Oliveira, Doron Lipson, Mark Kennedy, Mandy Greene, et al. "Circulating Tumor DNA and Biomarker Analyses From the LOTUS Randomized Trial of First-Line Ipatasertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer." JCO Precision Oncology, no. 4 (September 2020): 1012–24. http://dx.doi.org/10.1200/po.19.00396.
Full textZhou, Li, Maria Rueda, and Abedalrhman Alkhateeb. "Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network." Cancers 14, no. 4 (February 13, 2022): 934. http://dx.doi.org/10.3390/cancers14040934.
Full textBustos, Matias A., Jun Yin, Pavel Brodskiy, Irene Kang, Stephanie L. Graff, Sarah Sammons, Richa Dawar, David Spetzler, and Dave S. B. Hoon. "Association of interleukin-enhanced factor 2 (ILF2) expression with prognosis and clinico-genomic features in breast cancer (BC)." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 1030. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.1030.
Full textTisman, Glenn. "Cyber Cloud Oncology." Digital Medicine and Health Technology 2022 (August 25, 2022): 1–18. http://dx.doi.org/10.5772/dmht.08.
Full textHironaka-Mitsuhashi, Ai, Anna Sanchez Calle, Takahiro Ochiya, Shin Takayama, and Akihiko Suto. "Towards Circulating-Tumor DNA-Based Precision Medicine." Journal of Clinical Medicine 8, no. 9 (September 2, 2019): 1365. http://dx.doi.org/10.3390/jcm8091365.
Full textDackus, Gwen MHE, Natalie D. ter Hoeve, Mark Opdam, Willem Vreuls, Zsuzsanna Varga, Esther Koop, Stefan M. Willems, et al. "Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study." BMJ Open 7, no. 11 (November 2017): e017842. http://dx.doi.org/10.1136/bmjopen-2017-017842.
Full textMcDonnell, Kevin, Amit Kulkarni, Melissa Woodhouse, Sidney A. Smith, Christine Hong, Marilena Melas, Kathleen Heller, et al. "Advancing precision medicine in clinical oncology: Whole exome paired tumor-normal DNA and RNA sequencing at a single-institution cancer center." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e14006-e14006. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14006.
Full textLiegmann, Anna-Sophie, Kerstin Heselmeyer-Haddad, Annette Lischka, Daniela Hirsch, Wei-Dong Chen, Irianna Torres, Timo Gemoll, et al. "Single Cell Genetic Profiling of Tumors of Breast Cancer Patients Aged 50 Years and Older Reveals Enormous Intratumor Heterogeneity Independent of Individual Prognosis." Cancers 13, no. 13 (July 5, 2021): 3366. http://dx.doi.org/10.3390/cancers13133366.
Full textPremji, Sarah, Valentina Hoyos, Shaun Bulsara, Susan G. Hilsenbeck, Maryam Nemati Shafaee, Matthew James Ellis, C. Kent Osborne, Mothaffar F. Rimawi, and Julie R. Nangia. "Change in management based on actionable mutations in metastatic breast cancer in an ethnically diverse cohort: Single institution experience." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e13067-e13067. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e13067.
Full text